New agents for acute myelogenous leukemia
Open Access
- 7 March 2000
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 14 (3) , 488-490
- https://doi.org/10.1038/sj.leu.2401662
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancerNature Genetics, 1999
- Methylated DNA and MeCP2 recruit histone deacetylase to repress transcriptionNature Genetics, 1998
- Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complexNature, 1998
- Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF proteinOncogene, 1998
- Role of the histone deacetylase complex in acute promyelocytic leukaemiaNature, 1998
- Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemiaNature, 1998
- Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APLNature Genetics, 1998
- Agents that Down-Regulate or Inhibit Protein Kinase C Circumvent Resistance to 1-β-D-Arabinofuranosylcytosine-Induced Apoptosis in Human Leukemia Cells that Overexpress Bcl-2Molecular Pharmacology, 1997
- Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of CancersJNCI Journal of the National Cancer Institute, 1994
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971